Growth Metrics

Cabaletta Bio (CABA) Assets Average (2019 - 2025)

Cabaletta Bio's quarterly Assets Average came in at $177.4 million in Q4 2025, down 8.89% year-on-year from $194.7 million in Q4 2024, and down 14.34% quarter-over-quarter from $207.1 million in Q3 2025.

Cabaletta Bio has reported Assets Average for 7 years, with the latest figure at $177.4 million in Q4 2025.

  • For the quarter ending Q4 2025, Assets Average fell 8.89% year-over-year to $177.4 million; the trailing twelve-month figure through Dec 2025 stood at $177.4 million (down 8.89% YoY), and the FY2025 full-year result was $175.1 million, down 20.19% from the prior year.
  • Assets Average for Q4 2025 stood at $177.4 million, down from $207.1 million in the prior quarter.
  • The five-year high for Assets Average was $247.1 million in Q1 2024, with the low at $96.8 million in Q3 2022.
  • Average Assets Average over 5 years is $158.5 million, with a median of $159.6 million recorded in 2023.
  • Year-over-year, Assets Average jumped 124.17% in 2024 and slipped 29.13% in 2025.
  • Tracing CABA's Assets Average over 5 years: stood at $124.5 million in 2021, then decreased by 16.2% to $104.3 million in 2022, then surged by 104.63% to $213.5 million in 2023, then retreated by 8.78% to $194.7 million in 2024, then fell by 8.89% to $177.4 million in 2025.
  • The last three Assets Average figures came in at $177.4 million (Q4 2025), $207.1 million (Q3 2025), and $194.8 million (Q2 2025), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Assets Avg. (Qtr)
1 Quantum Biopharma 961,148.99 Bn 961,148.98 Bn - 13.04 Mn
2 Alterity Therapeutics 744,933.29 Bn 744,933.26 Bn - 33.42 Mn
3 Legend Biotech 2,540.00 Bn 2,539.71 Bn 242.10 Mn 1.72 Bn
4 Nanobiotix 2,199.85 Bn 2,199.78 Bn - 331.70 Mn
5 Akari Therapeutics 1,635.88 Bn 1,635.88 Bn - 40.89 Mn
6 Vertex Pharmaceuticals 111.32 Bn 104.07 Bn 2.59 Bn 26.06 Bn
7 Evaxion A 62.56 Bn 62.54 Bn - 26.03 Mn
8 Regeneron Pharmaceuticals 62.55 Bn 53.79 Bn 3.31 Bn 40.71 Bn
9 Alnylam Pharmaceuticals 39.57 Bn 36.56 Bn 959.66 Mn 5.05 Bn
10 Cabaletta Bio 194.84 Mn 61.24 Mn - 177.42 Mn

Historic Data

Download Data 🔒
DateValue
Dec 31, 2025 177.42 Mn
Sep 30, 2025 207.13 Mn
Jun 30, 2025 194.82 Mn
Mar 31, 2025 175.09 Mn
Dec 31, 2024 194.73 Mn
Sep 30, 2024 210.91 Mn
Jun 30, 2024 228.94 Mn
Mar 31, 2024 247.05 Mn
Dec 31, 2023 213.47 Mn
Sep 30, 2023 178.96 Mn
Jun 30, 2023 144.04 Mn
Mar 31, 2023 110.21 Mn
Dec 31, 2022 104.32 Mn
Sep 30, 2022 96.85 Mn
Jun 30, 2022 107.84 Mn
Mar 31, 2022 120.00 Mn
Dec 31, 2021 124.49 Mn
Sep 30, 2021 114.78 Mn
Jun 30, 2021 107.11 Mn
Mar 31, 2021 111.00 Mn
Dec 31, 2020 118.25 Mn
Sep 30, 2020 124.83 Mn
Jun 30, 2020 131.43 Mn
Mar 31, 2020 138.22 Mn
Dec 31, 2019 108.21 Mn